Since VIM-AS1 was predicted by an online tool to target miR-655, herein, we hypothesized that VIM-AS1 might act as a competing endogenous RNA (ceRNA) for miR-655 to offset miR-655-mediated inhibition of ZEB1, therefore modulating bladder cancer cell EMT. This evidence concerns the gene ZEB1 and urinary bladder carcinoma.